A submission was sent to Baroness Hooper recommending that Hepatitis C antibody screening should be introduced as a public health measure. Read more about A submission was sent to Baroness Hooper recommending that Hepatitis C antibody screening should be introduced as a public health measure.
A follow-up note of the sixth meeting of the Advisory Committee on the Virological Safety of Blood which Dr Robert Perry sent to Professor Cash additionally noted that Hepatitis C testing was in place in Finland and Australia. Read more about A follow-up note of the sixth meeting of the Advisory Committee on the Virological Safety of Blood which Dr Robert Perry sent to Professor Cash additionally noted that Hepatitis C testing was in place in Finland and Australia.
Dr Gunson reported to the SNBTS/NBTS Liaison Committee that Dr Lloyd had commenced anti-HCV testing within the past week at the Newcastle Regional Transfusion Centre. Read more about Dr Gunson reported to the SNBTS/NBTS Liaison Committee that Dr Lloyd had commenced anti-HCV testing within the past week at the Newcastle Regional Transfusion Centre.
At the tenth Advisory Committee on the Virological Safety of Blood meeting it was decided that Ortho II, Abbott II or UBI tests could be used for initial screening, at the choice of individual RTCs, guided by trial results so far. Dr Lloyd's "unilateral action" was regretted, but Dr Gunson suggested that it could be "used as an extension of the trial." Read more about At the tenth Advisory Committee on the Virological Safety of Blood meeting it was decided that Ortho II, Abbott II or UBI tests could be used for initial screening, at the choice of individual RTCs, guided by trial results so far. Dr Lloyd's "unilateral action" was regretted, but Dr Gunson suggested that it could be "used as an extension of the trial."
At the symposium Dr Barbara gave a talk on HCV and the Blood Transfusion Service which suggested that the predictive value of anti-HCV screening would be low in low prevalence populations. Read more about At the symposium Dr Barbara gave a talk on HCV and the Blood Transfusion Service which suggested that the predictive value of anti-HCV screening would be low in low prevalence populations.
Papers presented at the sixth meeting of the Advisory Committee on the Virological Safety of Blood included a report on the 8 February 1990 Hepatitis C Symposium. Read more about Papers presented at the sixth meeting of the Advisory Committee on the Virological Safety of Blood included a report on the 8 February 1990 Hepatitis C Symposium.
Ortho organised a second Hepatitis C Symposium in London. Read more about Ortho organised a second Hepatitis C Symposium in London.
Mr Justice Burton in "A and Others v National Blood Authority" recorded that "Dr Gunson accepted that, in retrospect, the fact that no preplanning was done for a year was obviously not satisfactory. Had there been counselling procedures in place, it appears to me that the system might have been able to cope, albeit with difficulty, as the West Midlands Report had indicated in December 1989, even without the confirmatory test". Read more about Mr Justice Burton in "A and Others v National Blood Authority" recorded that "Dr Gunson accepted that, in retrospect, the fact that no preplanning was done for a year was obviously not satisfactory. Had there been counselling procedures in place, it appears to me that the system might have been able to cope, albeit with difficulty, as the West Midlands Report had indicated in December 1989, even without the confirmatory test".
In "A and Others v National Blood Authority" Mr Justice Burton said he was satisfied that the basic requirements for implementing routine screening were the carrying out of pilot studies and evaluations, the planning for counselling and implementation, and the execution of that implementation in respect of equipment, staff and building works. Read more about In "A and Others v National Blood Authority" Mr Justice Burton said he was satisfied that the basic requirements for implementing routine screening were the carrying out of pilot studies and evaluations, the planning for counselling and implementation, and the execution of that implementation in respect of equipment, staff and building works.
After the FDA had granted a licence for the Ortho test, anti-HCV screening was still not introduced. Read more about After the FDA had granted a licence for the Ortho test, anti-HCV screening was still not introduced.